Olive ( DrugBank: Olive )

5 diseases

ID	Disease name (Link within this page)	Number of trials
13	Multiple sclerosis/Neuromyelitis optica	2
35	Pemphigus	1
49	Systemic lupus erythematosus	2
53	Sjogren syndrome	1
162	Pemphigoid	1

13. Multiple sclerosis/Neuromyelitis optica

Clinical trials : 3,340 / Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT04787497 (ClinicalTrials.gov)	December 2021	1/3/2021	The Effect of Extra Virgin Olive Oil in People With Multiple Sclerosis	The Neuropsychological Effects of Extra-Virgin Olive Oil in People With Multiple Sclerosis	Multiple Sclerosis	Dietary Supplement: High Phenolic Extra Virgin Olive Oil	University of Cyprus	World Olive Center for Health;Ellis-Farm, Eliama Daily Value	Not yet recruiting	18 Years	65 Years	All	100	N/A	NULL
2	NCT04120675 (ClinicalTrials.gov)	November 9, 2018	24/9/2019	Efficacy of Early Harvest Olive Oil in Cognition of Primary (PPMS) or Secondary (SPMS) Progressive Multiple Sclerosis	The Effects of Early Harvest Extra Virgin Olive Oil on Cognition and Mental Health of Primary (PPMS) or Secondary (SPMS) Progressive Multiple Sclerosis Patients	Progressive Multiple Sclerosis	Dietary Supplement: Early Harvest Extra Virgin Olive Oil	Aristotle University Of Thessaloniki	Greek Alzheimer's Association and Related Disorders;Ellis-Farm, Eliama Daily Value Gold (ellis-farm.com)	Completed	18 Years	65 Years	All	30	N/A	Greece

Clinical trials : 99 / Drugs : 124 - (DrugBank : 36) / Drug target genes : 23 - Drug target pathways : 169

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05594472 (ClinicalTrials.gov)	November 1, 2022	21/10/2022	Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid	Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid Compared to Conventional Topical Treatment	Pemphigus Vulgaris;Bullous Pemphigoid	Drug: Ozonated olive oil;Drug: Topical garamycin cream	Cairo University	NULL	Recruiting	18 Years	N/A	All	30	Phase 3	Egypt

Clinical trials : 993 / Drugs : 702 - (DrugBank : 184) / Drug target genes : 116 - Drug target pathways : 200

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05261529 (ClinicalTrials.gov)	November 3, 2021	8/2/2022	Effects of an Intervention With EVOO and Physical Activity in Patients With Systemic Lupus Erythematosus	Effects of a Nutricional Intervention With EVOO Oil and Physical Activity in Patients With Systemic Lupus Erythematosus: Effect on Clinical Course, Epigenetic and Microbiome	Lupus Erythematosus, Systemic	Dietary Supplement: Extra Virgin Olive Oil (EVOO);Behavioral: Physical Exercise Program	Universidad de Granada	Consejería de Economía, Innovación y Ciencia. Proyectos de I+D+I en el marco operativo Feder Andalucía 2014-2020	Recruiting	18 Years	70 Years	Female	90	N/A	Spain
2	NCT02021513 (ClinicalTrials.gov)	January 2012	13/12/2013	Pilot Study - Effect of Omega-3 on Systemic Lupus Erythematosus	Pilot Study - Effect of Omega-3 on Systemic Lupus Erythematosus	Systemic Lupus Erythematosus	Dietary Supplement: Fish Oil;Dietary Supplement: Olive Oil	University of Texas Southwestern Medical Center	NULL	Completed	18 Years	64 Years	Both	50	Phase 2	United States

Clinical trials : 305 / Drugs : 325 - (DrugBank : 104) / Drug target genes : 58 - Drug target pathways : 188

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01850979 (ClinicalTrials.gov)	February 2010	1/5/2013	Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops	Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops: Prospective Double-Blind Randomized Study	Sjogren Syndrome;Dry Eye Syndrome	Drug: Tacrolimus;Drug: Olive Oil	University of Sao Paulo General Hospital	NULL	Completed	40 Years	60 Years	Both	24	Phase 4	Brazil

Clinical trials : 90 / Drugs : 122 - (DrugBank : 47) / Drug target genes : 34 - Drug target pathways : 144

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05594472 (ClinicalTrials.gov)	November 1, 2022	21/10/2022	Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid	Ozonated Olive Oil in Treatment of Pemphigus Vulgaris and Bullous Pemphigoid Compared to Conventional Topical Treatment	Pemphigus Vulgaris;Bullous Pemphigoid	Drug: Ozonated olive oil;Drug: Topical garamycin cream	Cairo University	NULL	Recruiting	18 Years	N/A	All	30	Phase 3	Egypt